PolyPeptide Group AG (PPGN) — Capital Reinvestment Ratio
PolyPeptide Group AG (PPGN) has a Capital Reinvestment Ratio of 0.98x as of June 2025, meaning it reinvests 1% of its operating cash flow (CHF49.66 Million) in capital expenditures (CHF48.68 Million). See PolyPeptide Group AG (PPGN) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PolyPeptide Group AG Capital Reinvestment Ratio (2018–2024)
This chart tracks PolyPeptide Group AG's Capital Reinvestment Ratio across 7 annual periods. Check cash flow reinvestment rate of PolyPeptide Group AG to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for PolyPeptide Group AG (2018–2024)
Year-by-year Capital Reinvestment Ratio for PolyPeptide Group AG from 2018 to 2024. For live market cap and broader valuation context, see PolyPeptide Group AG market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.97x | CHF89.40 Million | CHF86.97 Million | ▼ -37.4% |
| 2023 | 1.55x | CHF36.48 Million | CHF56.73 Million | ▼ -89.2% |
| 2022 | 14.43x | CHF5.46 Million | CHF78.76 Million | ▲ +964.7% |
| 2021 | 1.35x | CHF57.35 Million | CHF77.71 Million | ▲ +65.0% |
| 2020 | 0.82x | CHF49.48 Million | CHF40.62 Million | ▲ +131.6% |
| 2019 | 0.35x | CHF55.60 Million | CHF19.70 Million | ▼ -55.6% |
| 2018 | 0.80x | CHF22.94 Million | CHF18.30 Million | — |